FTO rs3751812: Understanding Genetic Associations with Body Mass
The rs3751812 variant is a specific genetic change located within the FTO gene, which has been extensively studied for its potential link to body mass index and obesity. While research has identified statistical associations between this variant and weight-related traits, the evidence remains complex and varies across different ancestral populations.
What each genotype means
Baseline risk profile
This genotype is considered the baseline or normal state for this variant in the FTO gene. Research indicates that individuals with this genotype do not carry the specific allele associated with increased body mass index in this context.
This is the most common genotype in many populations, though frequencies vary significantly by ancestry.
Intermediate risk profile
Carrying one copy of the T allele may be associated with a modest increase in body mass index compared to those without the allele. The association is statistical in nature and does not determine individual health outcomes, as lifestyle and environmental factors play a major role.
This heterozygous genotype is found in a significant portion of the population, particularly among those of European ancestry.
Increased obesity risk
This genotype is associated with a higher body mass index and an increased predisposition to obesity in various studies. While this genetic marker is linked to these traits, it is only one of many factors influencing body weight, and it does not guarantee any specific health outcome.
This genotype is less common than the others, appearing in a smaller percentage of the population depending on ethnic background.
What is rs3751812?
The rs3751812 variant is a single nucleotide polymorphism (SNP) located within the FTO (fat mass and obesity-associated) gene. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. The FTO gene is situated on chromosome 16 and has gained significant attention in the scientific community because it was one of the first genes identified through genome-wide association studies (GWAS) to be linked to common forms of human obesity. The rs3751812 variant is one of many SNPs within this gene that researchers have investigated to understand how genetic architecture might influence human body composition. By mapping these variations, scientists aim to identify specific regions of the genome that may contribute to the biological pathways regulating energy balance and adiposity.
The Role of the FTO Gene
The FTO gene provides instructions for producing an enzyme that acts as a nucleic acid demethylase, which plays a role in various cellular processes. While the exact mechanisms by which FTO variants influence body weight are still being researched, the gene is highly expressed in the brain, particularly in areas involved in appetite regulation and energy homeostasis. Scientists hypothesize that variations in or near the FTO gene might alter the expression levels of the gene or its neighboring regulatory elements, potentially affecting how the body processes energy or signals hunger and satiety. Because the gene is involved in fundamental metabolic processes, it remains a primary focus for researchers studying the genetic underpinnings of obesity and metabolic health in diverse populations.
Research and Evidence Strength
The association between FTO variants and obesity-related traits is well-documented, particularly in populations of European ancestry. However, the evidence for rs3751812 specifically is considered limited or mixed compared to other, more prominent FTO variants. Some studies have reported a statistical correlation between this SNP and body mass index (BMI), while others have found no significant association or have noted that the effect size is relatively small. Furthermore, the strength of these associations often differs significantly between ancestral groups. For instance, some research has successfully replicated associations in African-derived populations, while other studies have suggested that the findings might be population-specific or even potential false positives. Because of these inconsistencies, the scientific community views the role of rs3751812 as a subject of ongoing investigation rather than a definitive predictor of health outcomes.
Population Frequency
The frequency of the rs3751812 variant varies across different global populations. In many studies, the minor allele frequency is relatively low, often reported around 10% in African-American cohorts and even lower, approximately 4% to 6%, in other specific populations such as the Yoruba. This contrasts with other well-known FTO variants that may have much higher frequencies in European populations. Because the prevalence of this specific SNP is not uniform, researchers must account for ancestral background when interpreting genetic data. Understanding these frequency differences is crucial for fine-mapping studies, which help scientists narrow down which specific genetic variations are truly functional and which are merely markers that happen to be inherited together due to their proximity on the chromosome.
Interpreting Genetic Information
It is important to understand that genetic variants like rs3751812 are associated with statistical trends in large populations, not individual medical outcomes. Having a particular genotype does not mean an individual will necessarily develop a specific body weight or health condition. Obesity is a complex, multifactorial trait influenced by a combination of genetic, environmental, and lifestyle factors, including diet, physical activity, and socioeconomic status. Genetic information should never be used to diagnose a condition or make medical decisions. If you have questions about your health, weight management, or how your genetic background might relate to your personal wellness, it is essential to consult with a qualified healthcare provider or a registered dietitian who can provide personalized guidance based on your complete health history.
How common is this variant?
The frequency of the rs3751812 variant is generally low, with minor allele frequencies typically observed between 4% and 10% depending on the ancestral population studied.
Frequently asked questions
Does having the rs3751812 variant mean I will be obese?
No. Genetic variants like rs3751812 are associated with small statistical differences in population averages and do not determine individual health outcomes. Obesity is influenced by many factors, including lifestyle, environment, and overall genetic makeup.
Is the FTO gene the only gene linked to obesity?
No, obesity is a polygenic trait, meaning it is influenced by hundreds of different genetic variants across the entire genome. FTO is simply one of the most well-known genes identified in early obesity research.
Should I get tested for the rs3751812 variant?
There is no clinical utility in testing for this specific variant for weight management purposes. Because the association is complex and influenced by many other factors, such a test would not provide actionable medical information.
How do I find out if I have this variant?
This variant is sometimes included in direct-to-consumer genetic testing panels. However, these results are for educational purposes and should not be used to make medical decisions or health assumptions.
Sources & further reading
Educational information only, last refreshed 10/16/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3751812?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in FTO
This variant is strongly associated with increased body mass index and obesity risk.
Variant in FTO associated with body mass index and obesity-related traits; evidence for sleep apnea is indirect via BMI.
Intronic regulatory variant in the FTO/IRX3 cluster strongly linked to elevated BMI, obesity susceptibility, and metabolic dysregulation.
Intronic SNP conferring a distinct preference for morning chronotype ('early bird' vs 'night owl') independently of metabolic phenotypes.
Intronic variant within the FTO locus, showing replicated association with body mass index and obesity risk.
Commonly associated with body mass index (BMI) and obesity risk, though sometimes misattributed in consumer genomics to facial morphology.
